Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma

J Gastroenterol Hepatol. 2016 Jul;31(7):1336-41. doi: 10.1111/jgh.13312.

Abstract

Background and aim: The Cancer of the Liver Italian Program (CLIP) score is a commonly used staging system for hepatocellular carcinoma (HCC) helpful with predicting prognosis of advanced HCC. CLIP uses the Child-Turcotte-Pugh (CTP) score to evaluate liver reserve. A new scoring system, the albumin-bilirubin (ALBI) grade, has been proposed as they objectively evaluate liver reserve. We examined whether the modification of CLIP with ALBI retained its prognosis prediction for patients with advanced HCC.

Methods: We included patients who received first-line antiangiogenic therapy for advanced HCC. Liver reserve was assessed using CTP and ALBI scores, which were then incorporated into CLIP and ALBI-CLIP, respectively. To assess their efficacies of prognostic prediction, the Cox's proportional hazard model and concordance indexes were used.

Results: A total of 142 patients were included; 137 of them were classified CTP A and 5 patients CTP B. Patients could be divided into four or five groups with different prognosis according to CLIP and ALBI-CLIP, respectively. Higher R(2) (0.249 vs 0.216) and lower Akaike information criterion (995.0 vs 1001.1) were observed for ALBI-CLIP than for CLIP in the Cox's model predicting overall survival. ALBI-CLIP remained an independent predictor for overall survival when CLIP and ALBI-CLIP were simultaneously incorporated in Cox's models allowing variable selection with adjustment for hepatitis etiology, treatment, and performance status. The concordance index was also higher for ALBI-CLIP than for CLIP (0.724 vs 0.703).

Conclusions: Modification of CLIP scoring with ALBI, which objectively assesses liver reserve, retains and might have improved prognosis prediction for advanced HCC.

Keywords: ALBI; CLIP; Child-Turcotte-Pugh; hepatocellular carcinoma; prognosis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bilirubin / blood
  • Biomarkers, Tumor / blood
  • Carcinoma, Hepatocellular / pathology*
  • Carcinoma, Hepatocellular / physiopathology*
  • Female
  • Forecasting
  • Humans
  • Liver / physiology*
  • Liver Function Tests / methods*
  • Liver Neoplasms / pathology*
  • Liver Neoplasms / physiopathology*
  • Male
  • Middle Aged
  • Neoplasm Staging / methods*
  • Organ Sparing Treatments
  • Prognosis
  • Serum Albumin
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Serum Albumin
  • Bilirubin